The mood at the annual meeting of the American Society of Cell and Gene Therapy isn’t amazing. The biotech market has been ...

Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.

Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year moratorium on ...

About 150 people in Singapore have transthyretin amyloid cardiomyopathy. Read more at straitstimes.com. Read more at ...

One of them is CRISPR Therapeutics ( CRSP -0.90%). It has an approved gene-editing therapy, but investors haven't been buying ...

Stylus will use the Eli Lilly and J&J-backed funds to advance its in vivo genetic medicines platform and develop its pipeline ...

In this Revvity GENCast episode 2, experts will discuss applications of gene editing to improve scientists’ understanding of the relationship between variant and disease in functional genomics studies ...

Danforth Technology Company launched Spearhead Bio to make the process of gene editing faster and more efficient.

Synthego Corp., which makes gene-editing tools for drug developers and other researchers, filed for bankruptcy with plans to ...

An appeals court has opened another chapter in the long-running CRISPR patent saga. | An appeals court has opened another ...

In a new study published in Cell Reports, researchers at the University of Freiburg reveal how a disordered protein segment ...

A new agtech company focused on enhancing gene editing for plants has launched in St. Louis, the Danforth Technology Company ...